(Q7041828)

Nivolumab (English)

17 November 2015

1 reference

European Medicines Agency product number

English

title

Nivolumab (English)

publication date

17 November 2015

type of chemical entity

0 references

active ingredient in

Nivolumab Bms

1 reference

EMEA/H/C/003840

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003840/human_med_001887.jsp

European Medicines Agency product number

22 March 2017

Opdivo

1 reference

EMEA/H/C/003985

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003985/human_med_001876.jsp

World Health Organisation international non-proprietary name

22 March 2017

nivolumab (English)

1 reference

English

title

Nivolumab (English)

medical condition treated

19 January 2016

head and neck squamous cell carcinoma

1 reference

2 October 2018

myelodysplastic syndrome

1 reference

2 October 2018

acute myeloid leukemia

1 reference

non-small-cell lung carcinoma

2 October 2018

1 reference

2 October 2018

benign mesothelioma

1 reference

2 October 2018

lymphoma

1 reference

2 October 2018

metastatic melanoma

1 reference

diffuse large B-cell lymphoma

2 October 2018

1 reference

tongue squamous cell carcinoma

2 October 2018

1 reference

renal clear cell carcinoma

2 October 2018

1 reference

2 October 2018

secondary neoplasm

1 reference

squamous cell carcinoma of the lung

2 October 2018

1 reference

2 October 2018

non-Hodgkin lymphoma

1 reference

2 October 2018

colon cancer

1 reference

transitional cell carcinoma

2 October 2018

1 reference

2 October 2018

bladder cancer

1 reference

benign pleural mesothelioma

2 October 2018

1 reference

2 October 2018

bronchus carcinoma

1 reference

2 October 2018

renal cell carcinoma

1 reference

2 October 2018

anal carcinoma

1 reference

2 October 2018

kidney cancer

1 reference

2 October 2018

hematologic cancer

1 reference

2 October 2018

melanoma

1 reference

2 October 2018

Merkel cell carcinoma

1 reference

physically interacts with

2 October 2018

programmed cell death 1

0 references

LiverTox likelihood score

LiverTox toxicity likelihood category E*

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Nivolumab

1 May 2016

1 reference

Nivolumab (English)

17 November 2015

1 reference

Nivolumab (English)

17 November 2015

1 reference

Medical Subject Headings

15 March 2018

Nivolumab 5GGR.png
3,564 × 4,096; 380 KB

0 references

Identifiers

1 reference

Nivolumab (English)

17 November 2015

1 reference

Hazardous Substances Data Bank

Nivolumab (English)

19 January 2016

1 reference

28 October 2019

NIVOLUMAB (English)

10 May 2021

0 references

0 references

Guide to Pharmacology Ligand ID

0 references

Nivolumab

0 references

MeSH tree code

D12.776.124.486.485.114.224.060.829

0 references

D12.776.124.790.651.114.224.060.829

0 references

D12.776.377.715.548.114.224.200.829

0 references

0 references

2 references

https://www.drugbank.ca/releases/latest#open-data

Nivolumab (English)

17 November 2015

April 2018

1 reference

English

title

NIVOLUMAB (English)

MedlinePlus drug identifier

19 January 2016

0 references

1 reference

NIVOLUMAB (English)

19 January 2016

1 reference

electronic Essential Medicines List medicine ID

Nivolumab (English)

19 January 2016

0 references

566

0 references

Freebase ID

/m/0j65pz5

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

0 references

1 reference

YSO-Wikidata mapping project